This trial is conducted in the United States of America (USA). The purpose of this study is
to test whether NovoLog (insulin aspart) is a safe and at least as effective alternative to
regular human insulin for the control of blood glucose after meals in women who develop
diabetes during pregnancy.
- Subjects older than 35 years old will be considered
- Gestational diabetes mellitus